Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
Wolfgang H Jost,1 Reiner Benecke,2 Dieter Hauschke,3 Joseph Jankovic,4 Petr Kaňovský,5 Peter Roggenkämper,6 David M Simpson,7 Cynthia L Comella81Department of Neurology, University of Freiburg, Freiburg, Germany; 2Clinic and Policlinic for Neurology, University of Rostock, Rostock, Germany; 3Institu...
Saved in:
Main Authors: | Jost WH (Author), Benecke R (Author), Hauschke D (Author), Jankovic J (Author), Kaňovský P (Author), Roggenkämper P (Author), Simpson DM (Author), Comella CL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
by: Yutskovskaya Y, et al.
Published: (2015) -
Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)
by: Meghdad Hosseini, et al.
Published: (2023) -
Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
by: Prager W
Published: (2013) -
Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA
by: Jörg Wissel, et al. -
Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women
by: Ada Trindade de Almeida, et al.
Published: (2024)